Institutional shares held 94.7 Million
263K calls
85.1K puts
Total value of holdings $1.47B
$4.07M calls
$1.32M puts
Market Cap $1.51B
95,046,400 Shares Out.
Institutional ownership 99.64%
# of Institutions 291


Latest Institutional Activity in TXG

Top Purchases

Q3 2024
Citadel Advisors LLC Shares Held: 2.78M ($44.2M)
Q3 2024
Ark Investment Management LLC Shares Held: 10.8M ($171M)
Q3 2024
Point72 Asset Management, L.P. Shares Held: 1.23M ($19.6M)
Q3 2024
Deerfield Management Company, L.P. (Series C) Shares Held: 1.51M ($24M)
Q3 2024
Vanguard Group Inc Shares Held: 11M ($174M)

Top Sells

Q3 2024
Baillie Gifford & CO Shares Held: 40.4K ($642K)
Q3 2024
Sands Capital Management, LLC Shares Held: 12.5K ($199K)
Q3 2024
Qube Research & Technologies LTD Shares Held: 65.2K ($1.04M)
Q3 2024
Millennium Management LLC Shares Held: 919K ($14.6M)
Q3 2024
Price T Rowe Associates Inc Shares Held: 2.52M ($40M)

About TXG

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.


Insider Transactions at TXG

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
320K Shares
From 12 Insiders
Grant, award, or other acquisition 297K shares
Exercise of conversion of derivative security 23.3K shares
Sell / Disposition
67.1K Shares
From 4 Insiders
Open market or private sale 62.4K shares
Bona fide gift 4.71K shares

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG